Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 17Observational 1

Sponsor

Cancer Type

CNS 15Head & Neck 12Thoracic 5Gastrointestinal 5Breast 4Genitourinary 3Sarcoma 2Other solid neoplasm 1Gynecologic 1Endocrine 1Dermatologic 1

Conditions

Ovarian Neoplasms 586Uterine Cervical Neoplasms 497Endometrial Neoplasms 319Breast Neoplasms 140Uterine Cervical Dysplasia 103Neoplasms 102Carcinoma, Ovarian Epithelial 90Fallopian Tube Neoplasms 78Lung Neoplasms 65Colorectal Neoplasms 64Uterine Neoplasms 61Vulvar Neoplasms 56Pancreatic Neoplasms 56Papillomavirus Infections 53Prostatic Neoplasms 52Stomach Neoplasms 49Colonic Neoplasms 47Peritoneal Neoplasms 41Melanoma 39Urinary Bladder Neoplasms 37Carcinoma, Non-Small-Cell Lung 37Esophageal Neoplasms 36Head and Neck Neoplasms 32Pelvic Neoplasms 29Vaginal Neoplasms 28Recurrence 28Rectal Neoplasms 27Ovarian Cysts 27Endometrial Hyperplasia 26Sarcoma 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Esthesioneuroblastoma, Olfactory × Gynecologic × Clear all
NCT01096381 2012-02-27

Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor

Vanderbilt-Ingram Cancer Center

Terminated
8 enrolled
BreastCNSGastrointestinalGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Fallopian Tube Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡